Search results for "SARS-CoV"
showing 10 items of 1220 documents
Southern Italy: How the Availability of Radiation Therapy, Patient Outcomes, and Risk to Health Care Providers Have Changed During the Coronavirus Di…
2020
The first actions and provisions in a Southern Italy Department of Radiation Oncology are described at the inception of the COVID-19 pandemic.
Impact of asymptomatic COVID-19 patients in global surgical practice during the COVID-19 pandemic
2020
The rapid spread of COVID-19 has changed the global surgical care. Patients infected with COVID-19 may present without typical symptoms, and such asymptomatic patients may potentially trigger in-hospital outbreaks by transmitting the disease to health care providers and other hospitalized patients. Further, asymptomatic COVID-19 patients have worse postop- erative outcomes with an unexpectedly high morbidity and mortality, reaching 20⋅5 per cent deaths. However, we do not have objective global data on this issue. In an attempt to clarify the current global surgical practice under the COVID-19 pandemic particularly focusing on the preoperative screening of asymptomatic COVID-19 patients, we …
Clinical utility of novel biosensing platform: Diagnosis of coronavirus SARS-CoV-2 at point of care
2021
Early detection is the first step in the fight against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Therefore, an efficient, rapid, selective, specific, and inexpensive SARS-CoV-2 diagnostic method is the need of the hour. The reverse transcription-polymerase chain reaction (RT-PCR) technology is massively utilized to detect infection with SARS-CoV-2. However, scientists continue to strive to create enhanced technology while continually developing nanomaterial-enabled biosensing methods that can provide new methodologies, potentially fulfilling the present demand for rapid and early identification of coronavirus disease 2019 (COVID-19) patients. Our review presents a summar…
The UK needs a sustainable strategy for COVID-19
2020
The UK is well into the second wave of COVID-19, with 60 051 lives lost to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection to date, according to provisional data from the Office for National Statistics. Official UK Government data show that cases have been rising exponentially since late August, 2020, with increases across all regions in England in recent weeks.As of Nov 4, 2020, the UK had 25 177 confirmed daily cases. These are almost certainly underestimates as between Oct 17 and Oct 23, 2020, England alone had 52 000 estimated daily cases.Estimates of the effective reproduction number in England vary between 1.1 and 1.6.Daily deaths have doubled every fortnight si…
The Association of Schools of Public Health in the European Region Statement on the Erosion of Public Health Systems
2021
Increase in admissions for anorexia nervosa after lockdown measures: Focus on a children's neuropsychiatry unit.
2021
ASPHER Statement
2021
Submitted by Agostinho Macau (arm@ucp.pt) on 2021-09-14T08:06:58Z No. of bitstreams: 1 ijph_66_1604361.pdf: 553290 bytes, checksum: 213f7a1eaedc390557eeae306bfc3262 (MD5) Made available in DSpace on 2021-09-14T08:06:58Z (GMT). No. of bitstreams: 1 ijph_66_1604361.pdf: 553290 bytes, checksum: 213f7a1eaedc390557eeae306bfc3262 (MD5) Previous issue date: 2021-08-23 info:eu-repo/semantics/publishedVersion
Comment on “ COVID ‐19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action”
2020
Cutaneous manifestation of COVID‐19 reporting from Middle‐Eastern countries: A point of view!
2020
Toxicity as prime selection criterion among SARS-active herbal medications
2021
We present here a new selection criterion for prioritizing research on efficacious drugs for the fight against COVID-19: the relative toxicity versus safety of herbal medications, which were effective against SARS in the 2002/2003 epidemic. We rank these medicines according to their toxicity versus safety as basis for preferential rapid research on their potential in the treatment of COVID-19. The data demonstrate that from toxicological information nothing speaks against immediate investigation on, followed by rapid implementation of Lonicera japonica, Morus alba, Forsythia suspensa, and Codonopsis spec. for treatment of COVID-19 patients. Glycyrrhiza spec. and Panax ginseng are ranked in …